Therasense, Inc. v. Becton, Dickinson and Company

Therasense, Inc. v. Becton, Dickinson and Company is a key U.S. Supreme Court case that clarified the standards for accusing someone of patent infringement through “inequitable conduct,” which involves deceitful behavior during patent application. The Court decided that additional proof of intent to deceive is necessary to prove inequitable conduct, making such claims harder to prove. This decision emphasizes that claims of misconduct must be supported by clear evidence and that allegations without sufficient proof are unjustified, thus raising the bar for accusing others of patent-related dishonesty.